We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.71%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
+$684M
(+16%)
Cap. Flow
+$419M
Cap. Flow
% of AUM
8.22%
Top 10 Holdings %
Top 10 Hldgs %
29.02%
Holding
1,104
New
355
Increased
287
Reduced
198
Closed
246
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$115M |
| 2 |
Bausch Health
BHC
|
+$84M |
| 3 |
Brookdale Senior Living
BKD
|
+$72M |
| 4 |
Abbott
ABT
|
+$56.3M |
| 5 |
AET
Aetna Inc
AET
|
+$56.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
+$160M |
| 2 |
Perrigo
PRGO
|
+$122M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$115M |
| 4 |
Amgen
AMGN
|
+$82M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$36.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.19% |
| 2 | Miscellaneous | 8.84% |
| 3 | Consumer Discretionary | 6.01% |
| 4 | Consumer Staples | 5.73% |
| 5 | Utilities | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GMCR
126
DELISTED
KEURIG GREEN MTN INC
GMCR
| $7.83M | 0.15% |
103,659
+99,846
| +2,619% | +$6.79M |
|
|
127
Amgen
AMGN
$203B
| $7.74M | 0.15% |
67,806
-720,741
| -91% | -$82M |
|
128
General Motors
GM
$74.9B
| $7.67M | 0.15% |
187,538
+152,135
| +430% | +$5.75M |
|
|
STJ
129
DELISTED
St Jude Medical
STJ
| $7.58M | 0.15% |
122,334
-36,135
| -23% | -$2.09M |
|
130
VanEck Oil Services ETF
OIH
$2.02B
| $7.52M | 0.15% |
+7,821
| New | +$7.62M |
|
131
Exelixis
EXEL
$14.1B
| $7.36M | 0.14% |
1,200,000
-100,000
| -8% | -$551K |
|
132
NXP Semiconductors
NXPI
$57.1B
| $7.3M | 0.14% |
158,969
-8,153
| -5% | -$336K |
|
133
Labcorp
LH
$26.3B
| $7.27M | 0.14% |
92,644
+79,671
| +614% | +$6.8M |
|
134
GameStop
GME
$10.8B
| $7.24M | 0.14% |
+588,152
| New | +$7.54M |
|
135
Sherwin-Williams
SHW
$78.5B
| $7.21M | 0.14% |
+117,870
| New | +$7.22M |
|
|
LPS
136
DELISTED
LENDER PROCESSING SERVICES INC
LPS
| $7.18M | 0.14% |
192,172
+10,430
| +6% | +$361K |
|
137
Hartford Financial Services
HIG
$36.8B
| $7.13M | 0.14% |
196,890
+101,010
| +105% | +$3.48M |
|
138
Ingredion
INGR
$6.25B
| $7.07M | 0.14% |
+103,283
| New | +$6.98M |
|
139
EOG Resources
EOG
$80.6B
| $6.93M | 0.14% |
+82,568
| New | +$7.08M |
|
|
NSTG
140
DELISTED
NanoString Technologies, Inc.
NSTG
| $6.89M | 0.14% |
399,900
+177,712
| +80% | +$2.2M |
|
141
Assembly Biosciences
ASMB
$532M
| $6.88M | 0.14% |
30,000
+5,000
| +20% | +$910K |
|
142
Insmed
INSM
$26.2B
| $6.83M | 0.13% |
401,462
-1,028
| -0.3% | -$15.7K |
|
143
Goodyear
GT
$1.51B
| $6.82M | 0.13% |
286,045
+44,155
| +18% | +$977K |
|
|
BRCM
144
DELISTED
BROADCOM CORP CL-A
BRCM
| $6.81M | 0.13% |
229,739
+101,162
| +79% | +$2.75M |
|
|
FISV
145
Fiserv Inc
FISV
$26.6B
| $6.8M | 0.13% |
+230,288
| New | +$6.21M |
|
146
eBay
EBAY
$48.1B
| $6.79M | 0.13% |
294,080
+66,459
| +29% | +$1.47M |
|
147
Skyworks Solutions
SWKS
$13.5B
| $6.73M | 0.13% |
235,580
+60,816
| +35% | +$1.59M |
|
148
Ralph Lauren
RL
$20B
| $6.66M | 0.13% |
37,699
+25,304
| +204% | +$4.31M |
|
149
Cameco
CCJ
$39.7B
| $6.65M | 0.13% |
+320,000
| New | +$6.21M |
|
|
CHTP
150
DELISTED
CHELSEA THERAPEUTICS INT'L LTD
CHTP
| $6.64M | 0.13% |
+1,500,000
| New | +$5.07M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2013 Portfolio in Review
As of Q4 2013, Visium Asset Management held 1,104 positions worth $5.09B, up 16% from $4.41B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Visium Asset Management deployed $419M of net new capital in Q4 2013, opening 355 new positions and adding to 287 existing holdings. Its largest new stake was Bausch Health: 766,970 shares worth $90M.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 55% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $122M trimmed.
- Visium Asset Management's largest Q4 2013 buy was Bausch Health: 766,970 shares worth $90M.
- Visium Asset Management added most to Allergan plc in Q4 2013, an estimated $115M increase.
- Visium Asset Management's biggest Q4 2013 reduction was Perrigo, cutting an estimated $122M.
- Visium Asset Management fully exited WARNER CHILCOTT PLC ORD SHS CL A (IRL) in Q4 2013, selling an estimated $160M.
- Visium Asset Management's ten largest holdings make up 29% of its $5.09B portfolio in Q4 2013.
- Visium Asset Management opened 355 new positions and closed 246 in Q4 2013.
- Visium Asset Management's portfolio value rose 16% quarter-over-quarter to $5.09B.
Based on Visium Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.